サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1301116

顧みられない熱帯病診断の市場規模、シェア、動向分析レポート：疾患別、診断方法別、サービスタイプ別、最終用途別、セグメント予測：2023年～2030年

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End Use, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 129 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
顧みられない熱帯病診断の市場規模、シェア、動向分析レポート：疾患別、診断方法別、サービスタイプ別、最終用途別、セグメント予測：2023年～2030年
出版日: 2023年06月22日
発行: Grand View Research
ページ情報: 英文 129 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顧みられない熱帯病診断市場の成長と動向

GrandView Research, Inc.の最新レポートによると、顧みられない熱帯病診断の世界市場規模は2030年までに89億7,000万米ドルに達し、予測期間中にCAGR 4.5％で拡大すると予測されています。

疾病負担の増加、疾病の早期発見に対する需要の高まり、技術の補完的進歩が需要の伸びを促進すると予想されます。

顧みられない熱帯病に対する関心の高まりと、それが人口だけでなく経済諸国に与える影響が、早期疾病検出法の開発需要を押し上げています。このような懸念の高まりは、NTDsとの闘いを目的とした多くのプログラムの立ち上げにも表れています。例えば、顧みられない熱帯病のための世界ネットワークは、最も一般的なNTDsの制圧と撲滅に不可欠な意識向上と資金調達を目指しています。さらに、さまざまな企業が、より複雑で安価な熱帯病診断法の開発に取り組んでいます。2021年1月、ノバルティスAGはWHOと、ハンセン病を全世界で管理する契約を締結しました。このことは、予測期間を通じてこの市場の成長を支えるものと予想されます。

WHOによると、2022年1月現在、世界中で15億人以上が土壌伝染蠕虫感染症に感染しています。カトー・カッツ法はWHOのゴールドスタンダードであり、STHsの強度を診断するために広く使用されています。これらの感染症は熱帯・亜熱帯地域に広く分布しており、アメリカ、サハラ以南のアフリカ、東アジア、中国で多く発生しています。さらに、主要プレイヤーの存在が市場全体の成長を促進すると予想されます。これらのプレーヤーが新製品開発に関与していることが、NTD診断市場の発展に寄与していると考えられています。

顧みられない熱帯病診断市場レポートハイライト

  • 疾患タイプ別では、土壌伝染性蠕虫病が2022年の市場を独占、これは有病率の増加と診断検査の採用率の高さ別。
  • 2022年の市場は、分子診断技術の研究開発とポイントオブケア製品の需要増加により、分子/最新診断分野が支配的
  • 2022年の市場シェアは、検査件数の多さ、インフラやマンパワーの面で補助的サポートが充実していることから、集中型サービスが最大セグメントを占めました。
  • 最終用途別では、POCTサービスの人気と需要が高まっていることから、在宅ヘルスケアが最も急成長する分野と予想される
  • アジア太平洋地域は、NTDsの疾病負担の大きさ、ヘルスケア支出の増加、急速な技術進歩、NTDsの診断におけるPCR検査の使用に関する顧客の意識の高まりにより、2022年の世界市場を独占します。
  • ラテンアメリカは、IVD製品の普及が進み、新興諸国におけるNTDsの疾病負担が大きいことから、今後大きく成長すると予想されます。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 市場の定義
    • 情報分析
    • 市場の形成とデータの視覚化
    • データの検証と公開
  • 調査の前提条件
  • 情報調達
    • 1次調査
  • 情報またはデータ分析
  • 市場の形成と検証
  • 市場モデル
  • 世界市場：CAGRの計算
  • 目的

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/アンシラリー市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 疾病ビジネス分析

  • 顧みられない熱帯病診断市場：疾病変動分析
  • デング熱
  • チクングニア熱
  • 狂犬病
  • ハンセン病
  • ブルーリ潰瘍
  • ヨーズ
  • リンパ系フィラリア症
  • 条虫症/嚢胞虫症
  • 食中毒吸虫感染症
  • エキノコックス症
  • シャーガス病
  • ドラクンキュリア症
  • ヒトアフリカトリパノソーマ症（睡眠病）
  • 土壌伝染性蠕虫症
  • オンコセルカ症
  • 住血吸虫症
  • 疥癬およびその他の生態寄生虫
  • ヘビ咬傷毒
  • リーシュマニア症

第5章 診断方法のビジネス分析

  • 顧みられない熱帯病の診断市場：診断方法の変動分析
  • 従来の方法
  • 分子/現代的手法

第6章 サービスタイプのビジネス分析

  • 顧みられない熱帯病診断市場：サービスタイプの変動分析
  • 一元化サービス
  • POCサービス

第7章 最終用途のビジネス分析

  • 顧みられない熱帯病診断市場：最終用途の変動分析
  • 臨床検査室
    • 臨床検査市場、2018年～2030年
    • 病院・診療所
    • 在宅ヘルスケア

第8章 地域ビジネス分析

  • 地域別の顧みられない熱帯病診断市場シェア、2022年および2030年
  • 北米
    • SWOT分析
    • 北米の顧みられない熱帯病診断市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州の顧みられない熱帯病診断市場、2018年～2030年
    • 英国
    • ドイツ
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋地域の顧みられない熱帯病診断市場、2018年～2030年
    • 中国
    • インド
    • インドネシア
    • マレーシア
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの顧みられない熱帯病診断市場、2018年～2030年
    • ブラジル
    • コロンビア
    • ベネズエラ
  • MEA
    • SWOT分析
    • MEA顧みられない熱帯病診断市場、2018年～2030年
    • ナイジェリア

第9章 競合情勢

  • 会社の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix, LLC
    • InBios International, Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • GmbH Oscar Medicare Pvt Ltd.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 5 Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 6 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 7 Global Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 10 North America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 11 North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 12 North America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 14 U.S. Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 15 U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Canada Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 19 Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 21 Europe Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 23 Europe Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 24 Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 25 Europe Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 26 UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 27 UK Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 28 UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 UK Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 Germany Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 32 Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 33 Germany Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 39 China Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 China Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 41 China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 42 China Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 43 India Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 44 India Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 45 India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 46 India Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 47 Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 48 Indonesia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 49 Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 50 Indonesia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 51 Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 52 Malaysia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 53 Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 54 Malaysia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 55 Latin America Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 56 Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 57 Latin America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 58 Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 59 Latin America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 60 Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 61 Brazil Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 62 Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 63 Brazil Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 64 Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 Colombia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 66 Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 67 Colombia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 68 Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 69 Venezuela Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 70 Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 71 Venezuela Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 77 Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 78 Nigeria Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 79 Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 80 Nigeria Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Neglected Tropical Diseases Diagnosis Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Neglected tropical diseases diagnosis market: Disease outlook and key takeaways
  • Fig. 15 Neglected tropical diseases diagnosis market: Disease movement analysis & market share 2022 & 2030
  • Fig. 16 Dengue neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 17 Chikungunya neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 18 Rabies market, 2018 - 2030 (USD Million)
  • Fig. 19 Leprosy neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 20 Buruli ulcer neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 21 Yaws market, 2018 - 2030 (USD Million)
  • Fig. 22 Lymphatic filariasis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 23 Taeniasis/Cysticercosis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 24 Foodborne trematode infections market, 2018 - 2030 (USD Million)
  • Fig. 25 Echinococcosis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 26 Chagas disease neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 27 Dracunculiasis market, 2018 - 2030 (USD Million)
  • Fig. 28 Human African trypanosomiasis (sleeping sickness) neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 29 Soil-transmitted helminthiases neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 30 Onchocerciasis market, 2018 - 2030 (USD Million)
  • Fig. 31 Schistosomiasis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 32 Scabies and other ecoparasites neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 33 Snakebite envenoming market, 2018 - 2030 (USD Million)
  • Fig. 34 Leishmaniases market, 2018 - 2030 (USD Million)
  • Fig. 35 Neglected tropical diseases diagnosis market: Diagnostic method outlook and key takeaways
  • Fig. 36 Neglected tropical diseases diagnosis market: Diagnostic method movement analysis & market share 2022 & 2030
  • Fig. 37 Conventional method market, 2018 - 2030 (USD Million)
  • Fig. 38 Molecular/Modern method market, 2018 - 2030 (USD Million)
  • Fig. 39 Neglected tropical diseases diagnosis market: Service type outlook and key takeaways
  • Fig. 40 Neglected tropical diseases diagnosis market: Service type movement analysis & market share 2022 & 2030
  • Fig. 41 Centralized service neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 42 POC service neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 43 Neglected tropical diseases diagnosis market: End-Use outlook and key takeaways
  • Fig. 44 Neglected tropical diseases diagnosis market: End-Use movement analysis & market share 2022 & 2030
  • Fig. 45 Clinical labs neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 46 Hospitals/Clinics neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 47 Home healthcare neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 48 Regional Marketplace: Key Takeaways
  • Fig. 49 Regional Outlook, 2022 & 2030
  • Fig. 50 Regional Market Dashboard
  • Fig. 51 Regional Market Place: Key Takeaways
  • Fig. 52 North America, SWOT Analysis
  • Fig. 53 Europe, SWOT Analysis
  • Fig. 54 Asia Pacific, SWOT Analysis
  • Fig. 55 Latin America, SWOT Analysis
  • Fig. 56 MEA, SWOT Analysis
  • Fig. 57 North America
  • Fig. 58 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 U.S.
  • Fig. 60 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Canada
  • Fig. 62 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Europe
  • Fig. 64 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 UK
  • Fig. 66 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Germany
  • Fig. 68 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 China
  • Fig. 72 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 74 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Indonesia
  • Fig. 76 Indonesia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Malaysia
  • Fig. 78 Malaysia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America
  • Fig. 80 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil
  • Fig. 82 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Colombia
  • Fig. 84 Colombia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 MEA
  • Fig. 86 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Nigeria
  • Fig. 88 Nigeria Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Strategy Mapping
目次
Product Code: GVR-2-68038-319-5

Neglected Tropical Diseases Diagnosis Market Growth & Trends

The global neglected tropical diseases diagnosis market size is expected to reach USD 8.97 billion by 2030, expanding at a CAGR of 4.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Disease Diagnosis Market Report Highlights

  • By disease type, the soil-transmitted helminthiases dominated the market in 2022, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2022, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2022 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2022, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of neglected tropical diseases
      • 3.2.1.2. Growing investments and governmental funding in the development of diagnostics
      • 3.2.1.3. Growing awareness of neglected tropical diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shift of funds to tackle other diseases in low health budgets
      • 3.2.2.2. Shortage of funding from international partners and foreign government
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Disease Business Analysis

  • 4.1. Neglected Tropical Disease Diagnosis Market: Disease Movement Analysis
  • 4.2. Dengue
    • 4.2.1. Dengue Market, 2018 - 2030 (USD Million)
  • 4.3. Chikungunya
    • 4.3.1. Chikungunya Market, 2018 - 2030 (USD Million)
  • 4.4. Rabies
    • 4.4.1. Rabies Market, 2018 - 2030 (USD Million)
  • 4.5. Leprosy
    • 4.5.1. Leprosy Market, 2018 - 2030 (USD Million)
  • 4.6. Buruli Ulcer
    • 4.6.1. Buruli Ulcer Market, 2018 - 2030 (USD Million)
  • 4.7. Yaws
    • 4.7.1. Yaws Market, 2018 - 2030 (USD Million)
  • 4.8. Lymphatic Filariasis
    • 4.8.1. Lymphatic Filariasis Market, 2018 - 2030 (USD Million)
  • 4.9. Taeniasis/Cysticercosis
    • 4.9.1. Taeniasis/Cysticercosis Market, 2018 - 2030 (USD Million)
  • 4.10. Foodborne Trematode Infections
    • 4.10.1. Foodborne Trematode Infections Market, 2018 - 2030 (USD Million)
  • 4.11. Echinococcosis
    • 4.11.1. Echinococcosis Market, 2018 - 2030 (USD Million)
  • 4.12. Chagas Disease
    • 4.12.1. Chagas Disease Market, 2018 - 2030 (USD Million)
  • 4.13. Dracunculiasis
    • 4.13.1. Dracunculiasis Market, 2018 - 2030 (USD Million)
  • 4.14. Human African Trypanosomiasis (Sleeping Sickness)
    • 4.14.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2018 - 2030 (USD Million)
  • 4.15. Soil-Transmitted Helminthiases
    • 4.15.1. Soil-Transmitted Helminthiases Market, 2018 - 2030 (USD Million)
  • 4.16. Onchocerciasis
    • 4.16.1. Onchocerciasis Market, 2018 - 2030 (USD Million)
  • 4.17. Schistosomiasis
    • 4.17.1. Schistosomiasis Market, 2018 - 2030 (USD Million)
  • 4.18. Scabies and Other Ecoparasites
    • 4.18.1. Scabies and Other Ecoparasites Market, 2018 - 2030 (USD Million)
  • 4.19. Snakebite Envenoming
    • 4.19.1. Snakebite Envenoming Market, 2018 - 2030 (USD Million)
  • 4.20. Leishmaniases
    • 4.20.1. Leishmaniases Market, 2018 - 2030 (USD Million)

Chapter 5. Diagnostic Method Business Analysis

  • 5.1. Neglected Tropical Disease Diagnosis Market: Diagnostic Method Movement Analysis
  • 5.2. Conventional Method
    • 5.2.1. Conventional Method Market, 2018 - 2030 (USD Million)
  • 5.3. Molecular/Modern Method
    • 5.3.1. Molecular/Modern Method Market, 2018 - 2030 (USD Million)

Chapter 6. Service Type Business Analysis

  • 6.1. Neglected Tropical Disease Diagnosis Market: Service Type Movement Analysis
  • 6.2. Centralized Service
    • 6.2.1. Centralized Service Market, 2018 - 2030 (USD Million)
  • 6.3. POC Service
    • 6.3.1. POC Service Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Neglected Tropical Disease Diagnosis Market: End-Use Movement Analysis
  • 7.2. Clinical Labs
    • 7.2.1. Clinical Labs Market, 2018 - 2030 (USD Million)
    • 7.2.2. Hospital/Clinics
      • 7.2.2.1. Hospital/Clinics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Home Healthcare
      • 7.2.3.1. Home Healthcare Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Neglected Tropical Disease Diagnosis Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Canada Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.5. Indonesia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Indonesia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.6. Malaysia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Malaysia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.4. Colombia
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Colombia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.5. Venezuela
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Venezuela Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.6.3. Nigeria
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Nigeria Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Abbott
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. ZeptoMetrix, LLC
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. InBios International, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Genome Diagnostics Pvt. Ltd.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Omega Diagnostics Group PLC
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Coris BioConcept
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. DiaSys Diagnostic Systems GmbH
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. GmbH Oscar Medicare Pvt Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives